Practice Area

Patent Litigation

Publications

June 6, 2017 Update on Biosimilar Approvals and Pending Applications in Europe and the U.S.

December 22, 2016 Discontent At Fed. Circ. Grows Post Cuozzo

April 27, 2016 A Breakthrough Technology is Caught in an Epic Patent Battle

March 16, 2016 Biosimilar Makers Turn To IPRs Despite Mixed Results

December 9, 2015 All Camps Agree: Memorable Biosimilar Names are a Must

October 27, 2015 TPP Biologics Exclusivity Period Maintains The Status Quo

June 2015 Biobetters: The Advantages and Challenges of Being Better

June 2015 New Targets in the Crosshairs: A forum to invalidate patents is now being used on biotech firms

April 2015 The Value of Being Highly Similar: First U.S. Biosimilar

October 2014 If High Court Reverses Teva, Litigation Costs May Increase

February 2012 FDA Issues Draft Guidelines for Biosimilars

January 2012 Partnering With The Feds For IP Enforcement: Part 1

June 2011 Supreme Court Decision: Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc.

May 2011 IP Audits: Making the Most of Your Intellectual Property

April 9, 2010 Federal Circuit Reinvigorates the Written Description Requirement

June 2009 On Appeal Alert: Federal Circuit Grants Mandamus on Motion to Transfer Venue

Spring 2008 IP OnTrial